SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-20-000031
Filing Date
2020-05-07
Accepted
2020-05-07 17:17:07
Documents
111
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bauschhealthcompaniesi.htm   iXBRL 10-Q 2845085
2 EXHIBIT 31.1 exhibit311q12020.htm EX-31.1 14624
3 EXHIBIT 31.2 exhibit312q12020.htm EX-31.2 14659
4 EXHIBIT 32.1 exhibit321q12020.htm EX-32.1 8932
5 EXHIBIT 32.2 exhibit322q12020.htm EX-32.2 8946
  Complete submission text file 0000885590-20-000031.txt   12688221

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200331.xsd EX-101.SCH 83650
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200331_cal.xml EX-101.CAL 125982
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200331_def.xml EX-101.DEF 462900
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200331_lab.xml EX-101.LAB 981301
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200331_pre.xml EX-101.PRE 637469
38 EXTRACTED XBRL INSTANCE DOCUMENT bauschhealthcompaniesi_htm.xml XML 2519531
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 20857649
SIC: 2834 Pharmaceutical Preparations